stock-mb-logo-androidstock-mb-logo-ios
Stock Screener App
무료 - Play StoreApp Store
설치하다설치하다
logo
Dow:  
Nasdaq:  
S&P 500:  
Fennec Pharmaceuticals IncFENC
$10.542.93%0.30
시간 외 거래: 10.540.00 0.00%

Fennec Pharmaceuticals Inc (FENC)

Date: 2026-11-02 16:00O: 10.37H: 10.60L: 10.01C: 10.54Vol: 183.1k
전일 마감가:
$10.24
열려 있는:
$10.13
하루 거래량:
183,119
상대 거래량:
1.57
시가총액:
$369.61M
수익:
$51.00M
순이익/손실:
-$8.73M
주가수익비율:
-
EPS:
-$0.2962
순현금흐름:
-$7.75M
1W 성능:
+3.84%
1M 성능:
+3.33%
6M 성능:
+61.16%
1Y 성능:
+28.54%
1일 변동 폭
$10.01$10.60
1주일 범위
$10.01$11.25
52주 변동 폭
$5.65$13.25

Fennec Pharmaceuticals Inc 주식 (FENC) 회사 개요

명칭
Fennec Pharmaceuticals Inc
전화
(919) 636-4530
주소
PO BOX 13628, RESEARCH TRIANGLE PARK, NC, USA
직원
35
다음 수익 날짜
2026-11-12
최신 SEC 제출 서류
SEC
X에서 FENC에 대한 토론
X

FENC vs VRTX, REGN, MRNA, ARGX, ONC 비교

주식시가총액매출순이익현금흐름주당 순 이익
FENC
Fennec Pharmaceuticals Inc
$369.61M$59.22M-$3.25M-$7.75M-$0.2962
VRTX
Vertex Pharmaceuticals Inc
$140.20B$12.59B$4.41B$3.71B$16.87
REGN
Regeneron Pharmaceuticals Inc
$99.44B$16.90B$4.82B$3.79B$41.04
MRNA
Moderna Inc
$88.16B$2.23B-$3.15B-$1.60B-$8.15
ARGX
Argen X Se Adr
$55.02B$4.16B$1.29B$734.26M$19.58
ONC
Beone Medicines Ltd Adr
$40.87B$6.13B$655.71M$1.10B$4.48

Fennec Pharmaceuticals Inc 주식(FENC) 업그레이드 및 다운그레이드

날짜액션분석자등급 변경
2026-02-12개시B. Riley SecuritiesBuy
2026-01-09개시Piper SandlerOverweight
2022-11-22업그레이드Cantor FitzgeraldNeutral → Overweight
2022-09-07개시CapitalOneOverweight

Fennec Pharmaceuticals Inc (FENC) 재무 분석

기간추세FY 2025FY 2024FY 2023FY 2022FY 2021
기간 종료일2025-12-312024-12-312023-12-312022-12-312021-12-31
Revenue USD (M)44.6447.5421.251.450.00
Cost of revenue USD (M)--1.260.09-
Gross profit USD (M)--19.991.45-
Research and development USD (M)0.250.310.063.534.98
Operating expenses USD (M)50.9244.9732.7624.0417.22
Operating income USD (M)-6.282.57-12.77-22.59-17.22
Income before tax USD (M)-9.64-0.07-16.05-23.71-17.35
Income tax expense USD (M)0.110.37-0.000.00
Net income USD (M)-9.74-0.44-16.05-23.71-17.35
Basic EPS USD/shares-0.34-0.02-0.60-0.90-0.67
Diluted EPS USD/shares-0.34-0.02-0.60-0.90-0.67
Basic weighted shares shares (M)28.5827.2926.5726.280.03
Diluted weighted shares shares (M)28.5827.2926.5726.280.03

Fennec Pharmaceuticals Inc 주식 (FENC) 내부자 거래

  • MARCO BRUGHERASep 15 '26
    Director
    거래
    Proposed Sale
    비용
    $10.30
    #주식
    15,545
    가치 ($)
    160,070
    #주식 총계
    0
  • Director
    거래
    Sale
    비용
    $10.29
    #주식
    15,545
    가치 ($)
    159,958
    #주식 총계
    0
  • Former Director
    거래
    Proposed Sale
    비용
    $12.12
    #주식
    10,000
    가치 ($)
    121,177
    #주식 총계
    0
  • Raykov RostySep 01 '26
    Former Director
    거래
    Sale
    비용
    $12.11
    #주식
    10,000
    가치 ($)
    121,100
    #주식 총계
    124,411
  • PIERRE S SAYADAug 31 '26
    Officer
    거래
    Proposed Sale
    비용
    $12.18
    #주식
    12,000
    가치 ($)
    146,170
    #주식 총계
    0
  • Chief Medical Officer
    거래
    Sale
    비용
    $12.18
    #주식
    12,000
    가치 ($)
    146,160
    #주식 총계
    9,519
  • Andrade RobertAug 28 '26
    CHIEF FINANCIAL OFFICER
    거래
    Option Exercise
    비용
    $5.10
    #주식
    21,928
    가치 ($)
    111,833
    #주식 총계
    239,603
  • ROBERT ANDRADEAug 27 '26
    Officer
    거래
    Proposed Sale
    비용
    $11.79
    #주식
    75,000
    가치 ($)
    883,898
    #주식 총계
    0
  • Andrade RobertAug 27 '26
    CHIEF FINANCIAL OFFICER
    거래
    Sale
    비용
    $11.78
    #주식
    75,000
    가치 ($)
    883,500
    #주식 총계
    217,675
  • Former Director
    거래
    Proposed Sale
    비용
    $9.58
    #주식
    10,000
    가치 ($)
    95,835
    #주식 총계
    0
내부자 거래관계날짜거래비용#주식가치 ($)#주식 총계
MARCO BRUGHERADirectorSep 15 '26Proposed Sale$10.3015,545160,0700
Brughera Marco MariaDirectorSep 15 '26Sale$10.2915,545159,9580
ROSTISLAV RAYKOVFormer DirectorSep 01 '26Proposed Sale$12.1210,000121,1770
Raykov RostyFormer DirectorSep 01 '26Sale$12.1110,000121,100124,411
PIERRE S SAYADOfficerAug 31 '26Proposed Sale$12.1812,000146,1700
Sayad Pierre SargisChief Medical OfficerAug 31 '26Sale$12.1812,000146,1609,519
Andrade RobertCHIEF FINANCIAL OFFICERAug 28 '26Option Exercise$5.1021,928111,833239,603
ROBERT ANDRADEOfficerAug 27 '26Proposed Sale$11.7975,000883,8980
Andrade RobertCHIEF FINANCIAL OFFICERAug 27 '26Sale$11.7875,000883,500217,675
ROSTISLAV RAYKOVFormer DirectorAug 03 '26Proposed Sale$9.5810,00095,8350

Fennec Pharmaceuticals Inc 주식(FENC)의 최신 뉴스

Oct 19, 2026
Oct 19, 2026
Oct 13, 2026
Oct 13, 2026
Oct 13, 2026
Oct 13, 2026
Oct 13, 2026
Oct 13, 2026
Oct 13, 2026
Oct 13, 2026
Oct 13, 2026
Oct 13, 2026
Oct 05, 2026
Oct 05, 2026
Oct 01, 2026
Oct 01, 2026
Oct 01, 2026
Oct 01, 2026
Oct 01, 2026
Oct 01, 2026
Oct 01, 2026
Oct 01, 2026
Oct 01, 2026
Oct 01, 2026
Sep 17, 2026
Sep 17, 2026
Sep 16, 2026
Sep 16, 2026
Sep 15, 2026
Sep 15, 2026
Sep 09, 2026
Sep 09, 2026
Sep 08, 2026
Sep 08, 2026
Sep 06, 2026
Sep 06, 2026
Sep 04, 2026
Sep 04, 2026
Sep 03, 2026
Sep 03, 2026
Sep 01, 2026
Sep 01, 2026
Sep 01, 2026
Sep 01, 2026
Sep 01, 2026
Sep 01, 2026
Sep 01, 2026
Sep 01, 2026
Aug 31, 2026
Aug 31, 2026
Aug 31, 2026
Aug 31, 2026
Aug 31, 2026
Aug 31, 2026
Aug 31, 2026
Aug 31, 2026
Aug 31, 2026
Aug 31, 2026
Aug 31, 2026
Aug 31, 2026
Aug 30, 2026
Aug 30, 2026
Aug 29, 2026
Aug 29, 2026
Aug 28, 2026
Aug 28, 2026
Aug 27, 2026
Aug 27, 2026
Aug 27, 2026
Aug 27, 2026
Aug 22, 2026
Aug 22, 2026
Aug 20, 2026
Aug 20, 2026
Aug 19, 2026
Aug 19, 2026
Aug 18, 2026
Aug 18, 2026
Aug 18, 2026
Aug 18, 2026
Aug 16, 2026
Aug 16, 2026
Aug 14, 2026
Aug 14, 2026
Aug 14, 2026
Aug 14, 2026
Aug 14, 2026
Aug 14, 2026
Aug 14, 2026
Aug 14, 2026
Aug 14, 2026
Aug 14, 2026
Aug 14, 2026
Aug 14, 2026
Aug 14, 2026
Aug 14, 2026
Aug 13, 2026
Aug 13, 2026
Aug 13, 2026
Aug 13, 2026

FENC와(과) 유사한 종목